Spiering Mary
Kaiser Westside Medical Center, Portland, Oregon. Mary Spiering, MN, RN-BC, CNS, is a clinical nurse specialist at Kaiser Westside Medical Center. This study was completed at Providence St. Vincent Medical Center, Portland, Oregon, where she was a cardiology clinical nurse specialist.
J Infus Nurs. 2014 Nov-Dec;37(6):453-60. doi: 10.1097/NAN.0000000000000072.
Intravenous amiodarone is one of the most widely used antiarrythmics for the treatment of atrial fibrillation with rapid ventricular response. Peripheral amiodarone infusion, however, often causes pain during infusion and subsequent phlebitis.Data collection on a cardiac telemetry unit revealed a high rate of phlebitis. A multidisciplinary team developed and implemented amiodarone peripheral infusion guidelines. The pre-guideline phlebitis rate was 85% and post-guideline rate was 38%, representing a 47% change or improvement. An additional finding was that the severity of phlebitis was reduced, as well. The results of this study suggest that the implementation of a peripheral amiodarone infusion guideline reduced the incidence and severity of amiodarone-related phlebitis in the cardiac population.
静脉注射胺碘酮是治疗快速心室反应性房颤最常用的抗心律失常药物之一。然而，外周静脉输注胺碘酮在输注过程中常引起疼痛及随后的静脉炎。心脏遥测病房的数据收集显示静脉炎发生率很高。一个多学科团队制定并实施了胺碘酮外周静脉输注指南。指南实施前静脉炎发生率为85%，实施后为38%，变化或改善率为47%。另一个发现是静脉炎的严重程度也有所降低。本研究结果表明，实施外周静脉胺碘酮输注指南可降低心脏疾病患者中胺碘酮相关静脉炎的发生率和严重程度。
